Stock Market News

AbbVie's migraine drug meets main goal in head-to-head study with topiramate

Jun 18, 2025 - 13:38
 0
AbbVie's migraine drug meets main goal in head-to-head study with topiramate
Read More

Tags:

Previous Article

US consumers more pessimistic on tariff costs, TransUnion says

Next Article

Hotel groups Hilton and Marriot announce African expansion plans

Related Posts

Hims to cut 4% of workforce amid ban on weight-loss drug copies

Hims to cut 4% of workforce amid ban on weight-loss dru...

May 31, 2025  0

What’s next for Fannie and Freddie under Trump administration?

What’s next for Fannie and Freddie under Trump administ...

Jun 8, 2025  0

Germany to cut electricity grid fees, tax in energy market push

Germany to cut electricity grid fees, tax in energy mar...

Jun 16, 2025  0